INO INOVIO PHARMACEUTICALS INC Management Changes 8-K Filing 2025 - Appointments On May 20, 2025, Inovio Pharmaceuticals held its Annual Meeting where stockholders voted on four proposals, including the election of directors and approval of accounting firm Ernst & Young for 2025; 54.59% of shares voted. The proposals results included significant support for board nominees and compensation plans, with the majority favoring the appointments and amendments outlined in the Proxy Statement.Get access to all SEC 8-K filings of the INOVIO PHARMACEUTICALS INC